Alpha Windward’s AngioDynamics ANGO Stock Holding History

Alpha Windward’s Portfolio ANGO Stock Details ANGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-20,100	Closed	-$459K	–	400
2019 Q1	$459K	Buy	+20,100	New	+$436K	0.31%	117

Other funds holding ANGO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

TCM

Tributary Capital Management Omaha, Nebraska $1.03B AUM 19.64% 1-Year Est. Return

Alpha Windward's ANGO Position: Q2 2019 in Review

Alpha Windward sold out of AngioDynamics (ANGO) in Q2 2019, closing a stake of 20,100 shares — an estimated $459K sold.

Alpha Windward first reported a position in ANGO in Q1 2019 and held it in 1 quarter. The position peaked at $459K in Q1 2019. 167 funds tracked by Wall St. Rank hold ANGO as of Q2 2019.

Alpha Windward reported no remaining AngioDynamics position as of Q2 2019 after selling out during the quarter.
Alpha Windward sold 20,100 AngioDynamics shares in Q2 2019, an estimated $459K.
Alpha Windward first reported a position in AngioDynamics in Q1 2019 and held it in 1 quarter.
Alpha Windward's AngioDynamics position peaked at $459K in Q1 2019.
167 funds tracked by Wall St. Rank held AngioDynamics as of Q2 2019.

Based on Alpha Windward's 13F filing for Q2 2019, filed 30 Jul 2019.